CEO Christer Alhberg presents at Redeye Healthcare Day 2026
Watch the full presentation by CEO Christer Ahlberg about Cinclus Pharma and the development of linaprazan glurate, presented at Redeye Healthcare Day 2026.
Read more
In the spotlight
Check out the latest updates from Cinclus Pharma
From summer job to groundbreaking research
Interview with Kjell Andersson – co-founder, Chief Scientific Officer, and since January 2026, board member of Cinclus Pharma
Read more
Magnus Christensen new CFO at Cinclus Pharma
Today we are excited to welcome our new CFO, Magnus Christensen, to the team.
Read more